Maab F. Elhaj

Maab F. Elhaj

Auto-generated profile, based on publicly available information

Maab F. Elhaj

Endocrine Division, Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Annals of Medicine
Verified
Journal Article
Open access
FAFateen Ata
Fateen Ata
AAArwa Ebrahim Y. A. Alsaud
Arwa Ebrahim Y. A. Alsaud
ARAli Ibrahim Rahil
Ali Ibrahim Rahil
MEMaab F. Elhaj
Maab F. Elhaj
AOAhmed Elmudathir Osman
Ahmed Elmudathir Osman
KBKhaled Baagar
Khaled Baagar
Adrenal vein sampling (AVS) is the gold standard for lateralizing aldosterone secretion in primary aldosteronism (PA) management. However, due to challenges in expertise and infrastructure, it remains underutilized in the Middle East (ME). This study aimed to document the performance and outcomes of AVS in the ME. This retrospective study included patients with PA who underwent AVS at a tertiary care hospital in Qatar (2015 - 2024). Clinical, biochemical, imaging and procedural data were collected to evaluate AVS success rates, imaging-AVS concordance and treatment outcomes. AVS success was defined as correct bilateral adrenal vein cannulation, determined by selectivity indices (unstimulated SI ≥ 2 or cosyntropin-stimulated SI ≥ 5). The cohort (n = 31) had a mean age of 50.29 ± 8.19 years, with a male predominance (67.7%). AVS was successful in 71% (n = 22). There was a 59% concordance between AVS and adrenal imaging. Of those with successful AVS (n = 22), adrenalectomy was performed in 54.5% of patients, with 66.7% requiring fewer antihypertensives than pre-AVS. Pre-AVS hypokalemia resolved in 75% of patients undergoing AVS-guided adrenalectomies vs. 20% in the medically managed group. This study is the first to demonstrate AVS's safety and efficacy in the ME, achieving a 71% success rate. With an AVS-imaging concordance of only 59%, the study highlights the clinical significance of AVS in guiding optimal management decisions. AVS-directed interventions lead to better treatment strategies with high post-treatment cure rates. The role of technology, such as intraprocedural dynaCT, is reinforced in improving procedural accuracy.

1 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
EAElabbass Ali Abdelmahmuod
Elabbass Ali Abdelmahmuod
MEMaab F. Elhaj
Maab F. Elhaj
MHMohamed Khair Hamad
Mohamed Khair Hamad
SIShahd I. Ibrahim
Shahd I. Ibrahim
MZMahmoud Zirie
Mahmoud Zirie
Thyroid nodules are commonly found in clinical practice, with a prevalence of 5%–7% on physical examination and up to 20%–67% when detected by high-resolution ultrasound in adults. The annual incidence of thyroid cancer varies significantly in different countries, ranging from 2.0 to 3.8/100,000 in women and from 1.2 to 2.6/100,000 individuals in men, with papillary thyroid cancer being the most frequently diagnosed type. While most of these nodules are nonfunctioning and benign, some may be hyperfunctioning (“hot” nodules), potentially causing thyrotoxicosis. Differentiated thyroid cancers, such as papillary and follicular thyroid carcinoma, are typically considered “cold” on scintigraphy, rarely presenting with hyperthyroidism. This case series describes a unique presentation of papillary and follicular thyroid carcinoma in two patients with thyrotoxicosis secondary to a hyperfunctioning nodule (“hot” nodule). Both patients presented with signs of hyperthyroidism. Diagnostic imaging revealed a hyperfunctioning thyroid nodule and subsequent histopathology confirmed the presence of both papillary and follicular carcinoma. This case series highlights the rare coexistence of differentiated thyroid cancer and thyrotoxicosis due to a hot nodule. It emphasizes the importance of thorough evaluation of hyperfunctioning nodules to rule out malignancy. Early recognition and appropriate management are crucial in optimizing patient outcomes.

1 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
EAElabbass Ali Abdelmahmuod
Elabbass Ali Abdelmahmuod
MEMaab F. Elhaj
Maab F. Elhaj
SIShahd I. Ibrahim
Shahd I. Ibrahim
SBSalma Bashir
Salma Bashir
EEElhadi Elouzi
Elhadi Elouzi
Normal pregnancy causes marked increases in lipids, but in women with underlying dyslipidaemia, this can lead to severe hypertriglyceridemia (triglyceride >1000 mg/dL) and acute pancreatitis. Coexisting conditions like diabetes and hypothyroidism further exacerbate this risk. We report a 34-year-old G2P1 woman at 32 weeks of gestation with type 2 diabetes and treated hypothyroidism who presented with acute pancreatitis and a serum triglyceride level of 33.8 mmol/L. Her management included therapeutic plasmapheresis, insulin infusion, and fenofibrate, followed by a planned elective caesarean section at 35 weeks, which resulted in the delivery of a healthy infant. This case highlights the critical need for vigilant lipid monitoring and a coordinated, multidisciplinary approach in high-risk pregnancies to prevent life-threatening complications and improve maternal and fetal outcomes.

1 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
MEMaab F. Elhaj
Maab F. Elhaj
EAElabbass Ali Abdelmahmuod
Elabbass Ali Abdelmahmuod
SBStephen F. Beer
Stephen F. Beer
TETarik Elhadd
Tarik Elhadd
Primary hyperaldosteronism (PHA) is a cause of secondary hypertension, often due to adrenal adenoma. The diagnosis and management of multiple unilateral adrenal adenomas in PHA represent a unique challenge. Adrenal venous sampling (AVS) has become a pivotal diagnostic tool in these cases, providing critical information for accurate localization of aldosterone production. Here, we describe a rare case of a 52-year-old female with a history of resistant essential hypertension who presented with multiple unilateral adrenal adenomas concomitant with adrenal hyperplasia in a case of primary hyperaldosteronism. The use of AVS in localization of aldosterone production was the determining factor in deciding the ultimate management of the patient, leading to successful follow-up on medical therapy with spironolactone.

3 March 2026 in Journal of Diabetes and Endocrine Practice
Verified
Journal Article
Open access
PDF file
MEMohsen S. Eledrisi
Mohsen S. Eledrisi
HAHaifaa Alkabbani
Haifaa Alkabbani
MAMalk Aboawon
Malk Aboawon
AAAya Ali
Aya Ali
IAImad Alabdulrazzak
Imad Alabdulrazzak
RMRAYAZ MALIK
RAYAZ MALIK
To assess the clinical characteristics of patients hospitalized with recurrent diabetic ketoacidosis (DKA). We examined the database for patients admitted with recurrent DKA (more than one admission) to government hospitals in Qatar over 6 years and compared them to patients with a single admission. A total of 1,612 patients with DKA were evaluated, of whom 434 patients (26.9%) had recurrent DKA. Compared with patients who had a single admission for DKA, those with recurrent DKA were younger (35.0 [24.0–53.0] vs. 39.0 [28.0–54.0] years, p < 0.001), more likely to be females (50.6 vs. 37.1%, p < 0.001), had a longer duration of diabetes (12.0 [5.0–19.0] vs. 5.0 [0.0–13.0] years, p < 0.001), more likely to have severe DKA (48.6 vs. 38%, p < 0.001), and had shorter time to resolution of DKA (12.5 [9.0–24.0] vs. 23.0 [10.0–33.0] hours, p < 0.001). There was no difference in the precipitating cause of DKA, need for admission to the intensive care unit, hospital stay, or inpatient mortality. On multivariable logistic regression analysis, significant predictors of recurrent DKA were younger age (odds ratio, 0.96; 95% confidence interval [CI]: 0.95–0.98; p = 0.0001), female gender (odds ratio, 0.63; 95% CI: 0.46–0.85; p = 0.003), and longer duration of diabetes (odds ratio, 1.07; 95% CI: 1.04–1.09, p = 0.0001). In this national cohort of patients, recurrent DKA was associated with younger age, female predominance, and longer duration of diabetes, but no difference in duration of hospital stay and inpatient mortality compared with patients with a single admission for DKA.